JCN Network - Home
JCN Newswire
 Search:    Companies  | Annual Reports  |  CSR  | News Alerts  |  Japanese   
Company
News Sectors
Automotive
Chemicals
Consumers
CSR
Electronics
Energy
Environment
Financial
Health & Med
Industrial
IT & Internet
Materials
Real Estate
Science & Tech
Telecoms
Trade
Transportation
Departments
Annual Reports
Companies
Trade Shows
News Alerts
News Search
Photo Gallery
Japan Corporate News Network
About JCN
Privacy Policy
RSS  
Terms of Use
 
Bookmark and Share
QSAI, Fukuoka University Confirm that Kale Has Property to Prevent and Improve Diabetes
 

Tokyo, Mar 31, 2006 (JCN) - QSAI has announced the results of its recent research on kale, a deep yellow vegetable. In collaboration with Fukuoka University, the company has examined how an intake of kale extract affects the condition of diabetes.

In mice experiments, the two partners confirmed that the extract helps inhibit the rise in blood glucose levels, and at the same time improves the activity of insulin and enhances the body's adipocyte glucose uptake capability.

Accordingly, the partners have concluded that the kale extract may play a role in preventing diabetes and improving diabetes control. Details of the research were presented at the 126th Annual Meeting of the Pharmaceutical Society of Japan held in Sendai on March 29.

By Aki Tsukioka Contributor

Copyright © 2010 JCN. All rights reserved. A division of Japan Corporate News Network KK.


 Company Profile |   Print  |   Alerts
ACN Newswire

 Recent  QSAI News  RSS  
  Nippon Supplement Confirms that Touchi Extract Improves Hyperlipidemia  (May 30, 2006)
  Q'SAI, Yamaguchi Prefectural University Discover that Kale Juice Helps Inhibit Immune Abnormality Associated with Passive Smoking  (May 26, 2006)
  Q'SAI, Yamaguchi Prefectural University Discover that Kale Juice Helps Inhibit Immune Abnormality Associated with Passive Smoking  (May 26, 2006)
  Q'SAI to Launch Multi-pesticide Residue Analysis Service for Imported Foods  (Apr 19, 2006)
  QSAI, Fukuoka University Confirm that Kale Has Property to Prevent and Improve Diabetes  (Mar 31, 2006)
  Q'SAI to Offer Antibiotic and Synthetic Antibacterial-Residue Analysis Service for Veterinary Medicines and Animal Feed Additives  (Feb 17, 2006)
  Q'SAI to Offer Upgraded Multi-pesticide Residue Analysis Service  (Jan 13, 2006)
  Q'SAI to Market Anti-aging Face Mask Richly Containing Fission Yeast Extracts  (Dec 1, 2005)
  Q'SAI Begins Offering Antibiotic and Synthetic Antibacterial-Residue Analysis Service for Stock Farm and Aquatic Products  (Nov 1, 2005)
  Q'SAI Begins Offering Multi-pesticide Residue Analysis Service that Covers Over 400 Pesticides  (Sept 6, 2005)



 Recent  Health/Medical News   RSS  
Asahi Kasei Integrates Bioprocess Businesses in North America (Dec 31, 2009)
Asahi Kasei Kuraray Medical Establishes Sales Subsidiary in Korea (Nov 1, 2009)
Asahi Kasei Launches 'Reveal DX' Insertable Cardiac Monitor (Oct 1, 2009)
New RIKEN Robot to Assist in Care Facilities (Sept 29, 2009)
Asahi Kasei Kuraray Medical Building Plant for Therapeutic Apheresis Devices (Sept 25, 2009)
Teijin Develops World's First Bioplastic Eyeglasses (Sept 4, 2009)
Astellas Establishes Fund Laboratory 'Genome Medical Science Laboratory' at the University of Tokyo (Sept 4, 2009)
Kuraray Mediacal Obtains Approval for Artificial Bone Graft (Sept 2, 2009)
Daiichi Sankyo, Ranbaxy Launch Psteoporosis Medication EVISTA in Romania (Sept 2, 2009)
Pfizer and Astellas to Co-promote Hypertension, Hypercholesterolemia Treatment (Aug 31, 2009)

More Health/Medical news...

 Recent  Health/Medical News   RSS  
Asahi Kasei Integrates Bioprocess Businesses in North America (Dec 31, 2009)
Asahi Kasei Kuraray Medical Establishes Sales Subsidiary in Korea (Nov 1, 2009)
Asahi Kasei Launches 'Reveal DX' Insertable Cardiac Monitor (Oct 1, 2009)
New RIKEN Robot to Assist in Care Facilities (Sept 29, 2009)
Asahi Kasei Kuraray Medical Building Plant for Therapeutic Apheresis Devices (Sept 25, 2009)
Teijin Develops World's First Bioplastic Eyeglasses (Sept 4, 2009)
Astellas Establishes Fund Laboratory 'Genome Medical Science Laboratory' at the University of Tokyo (Sept 4, 2009)
Kuraray Mediacal Obtains Approval for Artificial Bone Graft (Sept 2, 2009)
Daiichi Sankyo, Ranbaxy Launch Psteoporosis Medication EVISTA in Romania (Sept 2, 2009)
Pfizer and Astellas to Co-promote Hypertension, Hypercholesterolemia Treatment (Aug 31, 2009)

More Health/Medical news...
 
 
CSR Report Download
Annual Reports

  More >>    
Most Popular


About JCN | Privacy Policy | Terms of Use | JCN Network (日本語)